Founded in Germany, Synaptic Systems GmbH (SYSY Antibodies) focuses on the development and production of research antibodies for neuroscience, cell biology and immunology. Its scientific expertise centres on highly validated antibodies that enable researchers to investigate protein expression, cellular structure and biological function with confidence. The company supports antibody-based techniques used in immunohistochemistry, immunocytochemistry, Western blotting and related applications. Its resources also address specialised fields such as cortical development, blood-brain barrier biology and neurobiology research. A strong emphasis on validation and quality management helps ensure reproducible experimental performance across diverse laboratory workflows.
The product portfolio includes antibodies targeting neuronal, glial, immune and metabolic markers, alongside reagents for studying synaptic function, cell identity and tissue organisation. Researchers use these products to analyse molecular pathways, characterise cells and tissues, and investigate disease-relevant biological processes. The company also provides scientific resources, image atlases and methodological guidance that support experimental design and data interpretation. Products are developed for use across a wide range of basic and translational research applications in academia and industry.
Europa Biosite subsidiaries distribute SYSY Antibodies products in Belgium, Denmark, Estonia, Finland, Iceland, Latvia, Lithuania, Luxembourg, Netherlands, Norway, Sweden and Switzerland.
